2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC)

Incazelo emfushane:

Igama Lekhemikhali: 2-Chloro-5-Iodobenzoic Acid

CAS: 19094-56-5

I-Assay: ≥99.0% (HPLC)

Ukubukeka: Amakristalu Amhlophe noma Aphuzi Okuphaphathekile

I-Empagliflozin emaphakathi (CAS: 864070-44-0) yokwelashwa kwesifo sikashukela sohlobo 2

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukunikezwa Komkhiqizi, Ukuhlanzeka Okuphezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5

Chemical Properties:

Igama Lekhemikhali	I-2-Chloro-5-Iodobenzoic Acid
Inombolo ye-CAS	19094-56-5
Inombolo yeCAT	I-RF-PI438
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C7H4ClIO2
Isisindo samangqamuzana	282.46
Ukuncibilika	I-Soluble ku-Methanol
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Amakristalu Aphuzi Amhlophe noma Aphaphathekile
Indlela Yokuhlola / Yokuhlaziya	≥99.0% (HPLC)
I-Melting Point	161.0~163.0℃
Ukulahlekelwa Ekumisweni	≤0.50%
Izinsalela ekushiseni	≤0.20%
Ukungcola Okuphelele	≤1.0%
Izinsimbi Ezisindayo	≤20ppm
I-Residual Solvent	I-Ethanol
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Epagliflozin emaphakathi (CAS: 864070-44-0)

I-2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Umzila Wokwenziwa

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) ingasetshenziswa njengendawo yezemithi ekuhlanganiseni kwe-Empagliflozin (CAS: 864070-44-0).I-Empagliflozin (igama lokuhweba elithi Jardiance) iyi-inhibitor ye-sodium glucose co-transporter-2 (SGLT-2), futhi ibangela ukuthi ushukela osegazini ukhishwe yizinso futhi uphume emchamweni.Ngo-Agasti 1, 2014, i-Food and Drug Administration (FDA) yagunyaza ngokusemthethweni umuthi wokwelapha uhlobo lwesifo sikashukela sohlobo 2, ukuthuthukisa nokulawula ushukela wegazi kubantu abadala.I-Empagliflozin imithi yesithathu evimbela i-SGLT-2 egunyazwe yi-FDA.Eminye imithi emibili ye-SGLT-2 inhibitor, i-Canagliflozin ne-Dapagliflozin, okungekaJohnson Pharmaceuticals, i-AstraZeneca kanye ne-Bristol-Myers Squibb ngokulandelana, igunyazwe yi-FDA ngoNovemba 2013 nangoJanuwari 2014 ngokulandelana.